An investment made in a product that looks promising might turn out to be a bad commercial decision because of the factors that had not been predicted in advance. In order to avoid this scenario, we carry out SVIs in which the potential of the product is evaluated with a weighted score for a go or no-go decision.
Business cases include one of the most significant and valuable components of preliminary launch preparation: Insights from the field. Current market conditions are analyzed to find out the answers regarding receptiveness of the region to a new product and the need for the product in terms of treatment options.
Either through early access programs or market access authorization, we help you through all challenges on the way, understanding and meeting your needs comprehensively in each step, ensuring full compliance to local rules and regulations while providing full transparency.
We are here to offer you excellent know-how on Turkey and the Middle East market access procedures, and exhibit your product’s true potential through our extensive field reach.
With our expert knowledge in the field and action-driven approach, we can provide the Medical and Business services you need to ensure a successful product launch in the Middle East region.
We provide medical translation services for various content such as medical documents, clinical research documents and reports, medical reports, advertising and promotional texts, publications of the pharmaceutical industry.
The world is becoming more and more digitized, so are we! We offer medical website building and newsletter services at present, while many more on the way.
We offer high caliber service for your company’s need for third-parties on part-time or full-time, short-term or long-term basis, reaching relevant medical professionals suitable to your requirements.
We offer top-notch expertise in rare diseases centered in Turkey, the Middle East and Eastern Mediterranean Region.
Product launch is complex and challenging. But we are here to help you through! Turkish and Middle Eastern markets are marked by their high potential and large population size altogether, we have in-depth know-how of the region, and we want to build a sustainable partnership with you.
I have known Kivanc for more than 5 years. During this time, he worked in different positions in various pharmaceutical companies, and we carried out many projects together. He is a successful manager who stands out with his knowledge and experience in the pharmaceutical industry, especially in the rare disease area. He approaches every project in a detailed and result-oriented manner and delivers proactive solutions to surfacing problems. Having strong communication skills, Kivanc took his vision further and added new ones to his capabilities after establishing Trispera. In the light of my experience, my recommendation would be that you can have peace of mind, and leave all your projects to the leadership of Kivanc and the talented Trispera team.
Prof. Huseyin Onay, MD, PhD
Founder and Managing Director of Multigen Genetic Diseases Diagnosis Center
I have known Kivanc since he worked in AstraZeneca. He is open and transparent in his communication, and he places a high value on trust. He is customer-oriented and does not compromise on quality in his work. With his flexibility and ability to adapt quickly, he produces various solutions in a short time in response to changing conditions and demands. As TRPharm, we are extremely pleased with the quality of the work they have delivered in the projects that we did with Kivanc and his company, Trispera Consultancy. I would recommend working with Kıvanç and his team without hesitation.
Assoc. Prof. Tolga Tuncel, MD
TRPharm Pioneering Therapies Business Unit Director
We contacted Trispera at a time when we needed immediate guidance for a go or no-go decision regarding a product in 5 Gulf countries. There was insufficient data from the region at the outset. In a timeframe as short as 5 weeks, they brought an all-inclusive report that is abundant in concrete field information and full of practical insights. It contained more than 50 reflections from professionals of the region. We took our action with great confidence.
Samican Dabanlioglu, MD
TRPharm Strategic Business Unit Manager
Having previously worked with Kivanc, and being impressed with his work ethic, I employed him to work with Rhythm pharmaceuticals in 2018. He worked for me for 30 months, leading first in country efforts in Turkey and Greece. He was an award-winning top performer as an MSL at Rhythm and I expanded his remit to include national and international tasks. He became strategically strong during our time together, and his development was only aided by his hard working and calm manner. He produced national plans and his knowledge of the Turkish rare disease environment, and of the wider region, assisted the company's development beyond medical affairs. He developed a first-class knowledge of Turkish and Middle East Market Access and distribution over the 30 months. For Turkey and the Middle East rare disease or difficult to treat, in my opinion, he would be the "go to" person.
Former Rhythm Pharmaceuticals Medical Affairs Director
I have worked closely with Kivanc Oztuzun over the past 18 months and have found him to be a highly effective Medical Affairs professional. Kivanc’s physician background combined with his strong commercial acumen have made him the ideal partner from early phase development through to commercialisation. His understanding of pharma and biotech markets in Turkey, Greece and the Middle East is exceptional and his drive to succeed in these areas is palpable. Overall, Kivanc and Trispera have provided an excellent service and have contributed greatly to the health of our business.
Amplity Health Director of Field Operations, International